痛み抑制のためのアンジオテンシンII型2受容体
A H Jan Danser1, Praveen Anand2
1Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, Rotterdam 3015 CN, The Netherlands.
Cell
|June 21, 2014
まとめ
アンジオテンシンII型2型 (AT2) 受容体
科学分野:
- 心血管科学 心血管科学
- エンドクリノロジー エンドクリノロジー
- 薬理学 薬理学とは
背景:
- アンジオテンシンII (Ang II) の有害な作用は,主にAng II型1 (AT1) 受容体を通して媒介され,AT1受容体阻害剤 (ARB) と心血管疾患のACE阻害剤の開発につながります.
- 広範な研究にもかかわらず,Ang II型2受容体 (AT2) の正確な機能は,ほとんど不明のままです.
- AT2受容体の役割を理解することは,レニン-アニオテンシン系を標的とした新たな治療戦略の開発に不可欠です.
研究 の 目的:
- Ang II型2型受容体 (AT2) のほとんど未知の機能を解明する.
- 心血管生理学および病理生理学におけるAT2受容体の役割に関する進行中の研究に新しい発見を寄与する.
- AT2受容体の関与について,既知のAT1受容体媒介効果を超えて,より深い理解を提供するためです.
主な方法:
- マリオンらによる研究. AT2受容体の機能に関する新しい洞察を紹介しています.
- Marion et al.によって使用された特定の実験的アプローチ. 完全な出版物の中で詳細に記載されています.
- この研究は,AT2受容体のシグナル伝達経路を調査するために,in vitroおよび/またはin vivoモデルを含む可能性が高い.
主要な成果:
- マリオンらによる研究. AT2受容体に関する私たちの知識を前進させる新しい発見を提示します.
- これらの結果は,AT2受容体の生理学的または病理学的プロセスへの貢献に関する新しい視点を提供します.
- 特定のアウトカムでは,AT2受容体活性化に関連するこれまで認識されていない役割やメカニズムが強調されています.
結論:
- マリオンらによる研究. AT2受容体の理解に重要な新しい章を追加します.
- AT2受容体に関するさらなる調査は,その治療的可能性を完全に理解するために正当化されています.
- これらの発見は,AT1受容体阻害とは異なるレニン-アニオテンシン系内の新しい治療標的の道を開く可能性があります.
関連する概念動画
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.9K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.9K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.7K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.8K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.8K
01:31Adrenergic Receptors: ɑ Subtype
2.7K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.7K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.7K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.7K
01:29Hypertension II: Pathophysiology
1.7K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.7K